PetMed Express (PETS)
(Delayed Data from NSDQ)
$4.02 USD
-0.03 (-0.74%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $4.02 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth A Momentum A VGM
Balance Sheet
Fiscal Year End for PetMed Express, Inc falls in the month of March.
All items in Millions except Per Share data.
3/31/2024 | 3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 104 | 111 | 119 | 104 |
Receivables | NA | 2 | 2 | 3 | 4 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 19 | 32 | 34 | 18 |
Other Current Assets | NA | 7 | 6 | 5 | 4 |
Total Current Assets | NA | 131 | 151 | 161 | 129 |
Net Property & Equipment | NA | 26 | 24 | 25 | 25 |
Investments & Advances | NA | 0 | 0 | 0 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 1 | 0 | 0 | 0 |
Intangibles | NA | 6 | 1 | 1 | 1 |
Deposits & Other Assets | NA | 0 | 0 | 0 | 0 |
Total Assets | NA | 164 | 176 | 188 | 155 |
Liabilities & Shareholders Equity | 3/31/2024 | 3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 25 | 28 | 40 | 20 |
Current Portion Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 11 | 6 | 5 | 4 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 0 | 0 | 0 | 0 |
Total Current Liabilities | NA | 37 | 33 | 45 | 24 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 0 | 1 | 1 | 1 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 4 | 0 | 0 | 0 |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 40 | 34 | 46 | 25 |
Shareholders Equity | 3/31/2024 | 3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 0 | 0 | 0 | 0 |
Capital Surplus | NA | 18 | 12 | 7 | 4 |
Retained Earnings | NA | 105 | 131 | 134 | 126 |
Other Equity | NA | 0 | 0 | 0 | 0 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 124 | 142 | 141 | 130 |
Total Liabilities & Shareholder's Equity | NA | 164 | 176 | 188 | 155 |
Total Common Equity | 0 | 124 | 142 | 141 | 130 |
Shares Outstanding | 21.10 | 21.00 | 20.90 | 20.20 | 20.10 |
Book Value Per Share | 0.00 | 5.89 | 6.80 | 6.99 | 6.47 |
Fiscal Year End for PetMed Express, Inc falls in the month of March.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 49 | 53 | 62 | 104 |
Receivables | NA | 2 | 2 | 2 | 2 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 35 | 19 | 32 | 19 |
Other Current Assets | NA | 10 | 11 | 10 | 7 |
Total Current Assets | NA | 96 | 86 | 106 | 131 |
Net Property & Equipment | NA | 27 | 27 | 27 | 26 |
Investments & Advances | NA | 0 | 0 | 0 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 6 | 5 | 7 | 1 |
Intangibles | NA | 44 | 40 | 38 | 6 |
Deposits & Other Assets | NA | 0 | 0 | 0 | 0 |
Total Assets | NA | 173 | 159 | 181 | 164 |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 39 | 25 | 40 | 25 |
Current Portion Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 6 | 11 | 13 | 11 |
Income Taxes Payable | NA | 24 | 0 | 0 | 0 |
Other Current Liabilities | NA | 3 | 4 | 3 | 0 |
Total Current Liabilities | NA | 72 | 41 | 57 | 37 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 0 | 0 | 0 | 0 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 4 | 4 | 4 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 73 | 46 | 62 | 40 |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 0 | 0 | 0 | 0 |
Capital Surplus | NA | 23 | 22 | 20 | 18 |
Retained Earnings | NA | 77 | 92 | 98 | 105 |
Other Equity | NA | 0 | 0 | 0 | 0 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 100 | 114 | 118 | 124 |
Total Liabilities & Shareholder's Equity | NA | 173 | 159 | 181 | 164 |
Total Common Equity | 0 | 100 | 114 | 118 | 124 |
Shares Outstanding | 21.10 | 21.10 | 21.10 | 21.10 | 21.00 |
Book Value Per Share | 0.00 | 4.74 | 5.39 | 5.61 | 5.89 |